# 44-year journey (1980–2024): scientometric insights into Sigesbeckiae herba and update on its medicinal properties and phytochemicals profile

**Authors:** Parsa Dar, Cui Wenqing, Shaden A. M. Khalifa, Junming Chen, Kegang Linghu, Wei Xiong, Hesham R. El-Seedi, Hua Yu

PMC · DOI: 10.1186/s13020-025-01308-6 · Chinese Medicine · 2026-03-04

## TL;DR

This paper reviews 44 years of research on Sigesbeckiae Herba, highlighting its medicinal uses, phytochemicals, and the need for more collaboration in its study.

## Contribution

The study provides a comprehensive scientometric analysis and updated insights into the medicinal and phytochemical profile of Sigesbeckiae Herba.

## Key findings

- China leads in SH research, with limited international collaboration.
- Key research areas include anti-inflammation, rheumatic arthritis, and NF-κβ pathways.
- Over 300 phytochemicals, including flavonoids and diterpenoids, were identified in SH.

## Abstract

This study uses Scientometric analysis to review Sigesbeckiae Herba (SH) research worldwide from 1980 to 2024. Data-driven analysis identifies patterns, partnerships, and possibilities. Due to its wide profile and traditional medical uses, SH is gaining attention, according to this research. China has made the most important contributions to SH research, followed by the United stated of America and Korea. Countries and organizations have not collaborated on SH research. We found “anti-inflammation,” “rheumatic arthritis,” and “NF-κβ” using keyword co-occurrence analysis. Citation analysis showed SH research's most prominent institutions, journals, and authors, offering a complete snapshot of organization and diffusion. The data shows that this subject has received substantial academic interest despite a reduction in publications since 2019. These findings highlight the need for cooperation, multidisciplinary methods, and attention to underrepresented disciplines for academics, funding organizations, and policymakers. SH has been used to cure inflammation. Sigesbeckia orientalis L., S. pubescens Makino, and S. glabrescens Makino are the primary botanical sources. This research extensively evaluates SH literature, focusing on its botanical properties, bioactive components, pharmacological effects, and probable toxicity. More than three hundred phytochemicals, including flavonoids, diterpenoids, sesquiterpenoids, oxylipins, and lignoids, were identified in the extract, many of which are known to exert diverse biological effects. The extracts of SH are used in traditional Chinese medicine (TCM) due to its immunomodulatory, anti-inflammatory, and anti-cancer activities and are being considered for cosmetics and skin issues. Pharmacological benefits of diterpenoids, sesquiterpenoids, and flavonoids are found. The study recommends further research and cooperation to enhance TCM and herbal research by comparing the chemical and pharmacological properties of these three SH species.

The online version contains supplementary material available at 10.1186/s13020-025-01308-6.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** oxylipins (PubChem CID 44581450)

## Full-text entities

- **Genes:** Hmox1 (heme oxygenase 1) [NCBI Gene 15368] {aka D8Wsu38e, HO-1, HO1, Hemox, Hmox, Hsp32}, GCLM (glutamate-cysteine ligase modifier subunit) [NCBI Gene 2730] {aka GLCLR}, Ighg1 (immunoglobulin heavy constant gamma 1 (G1m marker)) [NCBI Gene 16017] {aka IgG1, Igh-4, VH7183}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 17246] {aka 1700007J15Rik, Mdm-2}, Tff2 (trefoil factor 2) [NCBI Gene 116592], Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Mapk14 (mitogen-activated protein kinase 14) [NCBI Gene 26416] {aka CSBP2, Crk1, Csbp1, Mxi2, PRKM14, PRKM15}, KDR (kinase insert domain receptor) [NCBI Gene 3791] {aka CD309, FLK1, VEGFR, VEGFR2}, Mapk8 (mitogen-activated protein kinase 8) [NCBI Gene 26419] {aka JNK, JNK1, Prkm8, SAPK1}, Tff2 (trefoil factor 2 (spasmolytic protein 1)) [NCBI Gene 21785] {aka SP, mSP}, Fgfr1 (fibroblast growth factor receptor 1) [NCBI Gene 14182] {aka Eask, FGFR-I, FLG, Fgfr-1, Flt-2, Fr1}, Dnah8 (dynein, axonemal, heavy chain 8) [NCBI Gene 13417] {aka ATPase, Dnahc8, Hst6.7b, P1-Loop}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, H6PD (hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase) [NCBI Gene 9563] {aka CORTRD1, G6PDH, GDH, H6PDH}, Il1 (interleukin 1 complex) [NCBI Gene 111343] {aka Il-1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Sirt1 (sirtuin 1) [NCBI Gene 93759] {aka SIR2L1, Sir2, Sir2a, Sir2alpha}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 17709], Tnfrsf11b (tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)) [NCBI Gene 18383] {aka OCIF, Opg, TR1}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 22329] {aka CD106, Vcam-1}, Ptpn1 (protein tyrosine phosphatase, non-receptor type 1) [NCBI Gene 19246] {aka PTP-1B, PTP-HA2, PTP1B}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Mapk10 (mitogen activated protein kinase 10) [NCBI Gene 25272] {aka Jnk3, SAPKC, SAPb, Serk2}, Traf6 (TNF receptor-associated factor 6) [NCBI Gene 22034] {aka 2310003F17Rik, C630032O20Rik}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 314856], F2 (coagulation factor II, thrombin) [NCBI Gene 29251], GCLC (glutamate-cysteine ligase catalytic subunit) [NCBI Gene 2729] {aka CNSHA7, GCL, GCS, GLCL, GLCLC}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CAT (catalase) [NCBI Gene 847], Serpinb1-ps1 (serine (or cysteine) peptidase inhibitor, clade B, member 1, pseudogene) [NCBI Gene 282665] {aka EID, ovalbumin}, Foxo1 (forkhead box O1) [NCBI Gene 56458] {aka Afxh, FKHR, Fkhr1, Foxo1a}, Mapk10 (mitogen-activated protein kinase 10) [NCBI Gene 26414] {aka C230008H04Rik, JNK3, JNK3B1, JNK3B2, SAPK(beta), Serk2}, Ighg2b (immunoglobulin heavy constant gamma 2B) [NCBI Gene 16016] {aka IgG2b, Igh-3, gamma2b}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Suox (sulfite oxidase) [NCBI Gene 211389] {aka SO}, Igh-V7183 (immunoglobulin heavy chain (V7183 family)) [NCBI Gene 16059] {aka B9-scFv, IgG, IgH, IgVH1(VSG), VH7183, VI24H}, Cd5l (CD5 antigen-like) [NCBI Gene 11801] {aka 1/6, AAC-11, AIM, Api6, CT2, Pdp}, WNK1 (WNK lysine deficient protein kinase 1) [NCBI Gene 65125] {aka HSAN2, HSN2, KDP, PPP1R167, PRKWNK1, PSK}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Cdk5 (cyclin-dependent kinase 5) [NCBI Gene 140908], Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Il3 (interleukin 3) [NCBI Gene 16187] {aka BPA, Csfmu, HCGF, Il-3, MCGF, PSF}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Cdk5 (cyclin dependent kinase 5) [NCBI Gene 12568] {aka Crk6}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}
- **Diseases:** neuroinflammation (MESH:D000090862), rheumatic arthritis (MESH:D012213), gouty arthritis (MESH:D015210), diabetes (MESH:D003920), Cerebral ischemia (MESH:D002545), weakness (MESH:D018908), cancer (MESH:D009369), Alzheimer's and multiple sclerosis (MESH:D000544), lung cancer (MESH:D008175), pancreatic cancer (MESH:D010190), gout (MESH:D006073), skin (MESH:D012871), myocardial remodelling (MESH:D064752), cervical cancer (MESH:D002583), platelet aggregation (MESH:D001791), fibrosis (MESH:D005355), neurodegenerative illnesses (MESH:D019636), liver, and heart diseases (MESH:D008107), ankle joint inflammation (MESH:D007249), analgesia (MESH:D000699), fever (MESH:D005334), psoriasis (MESH:D011565), ischemia (MESH:D007511), osteoarthritis (MESH:D010003), psoriatic arthritis (MESH:D015535), KDPs (MESH:D006969), blood stasis (MESH:D014647), myocardial injury (MESH:D009202), dermatitis (MESH:D003872), lung adenocarcinoma (MESH:D000077192), osteoporosis (MESH:D010024), rheumatism (MESH:D012216), numbness (MESH:D006987), joint swelling (MESH:D007592), cytotoxic (MESH:D064420), SO (MESH:D007926), cerebral infarction (MESH:D002544), DTH (MESH:D006968), coagulation (MESH:D001778), atherosclerotic (MESH:D050197), hypertensive (MESH:D006973), blood (MESH:D006402), diabetic cardiomyopathy (MESH:D058065), neurological system damage (MESH:D020196), hyperinsulinemia (MESH:D006946), Rheumatoid arthritis (MESH:D001172), reperfusion injury (MESH:D015427), Thrombosis (MESH:D013927), lung metastasis (MESH:D009362), arthritis (MESH:D001168), ulcerative colitis (MESH:D003093), malaria (MESH:D008288), cardiac injury (MESH:D006331), Anti-allergic (MESH:D004342), breast cancer (MESH:D001943), kidney inflammation (MESH:D007674)
- **Chemicals:** C (MESH:D002244), oxirane (MESH:D005027), flavonols (MESH:D044948), Rutin (MESH:D012431), C-14 (MESH:C000615234), uric acid (MESH:D014527), Pimarane (MESH:C433018), beta-Sitosterol (MESH:C025473), quercetin (MESH:D011794), ethylene glycol (MESH:D019855), allopurinol (MESH:D000493), dioxygen (MESH:D010100), Siegeskaurolic acid (MESH:C518478), tribulusamide A (MESH:C115947), Spathulenol (MESH:C013258), 5,3'-dihydroxy-3,7,4'-trimethoxyflavone (MESH:C459623), Kirenol (MESH:C560087), cadinane (MESH:C508039), methanol (MESH:D000432), chalcone (MESH:D002599), (+)-syringaresinol (MESH:C042192), blood glucose (MESH:D001786), aldehyde (MESH:D000447), , B (MESH:D001895), hyaluronic acid (MESH:D006820), cyclophosphamide (MESH:D003520), alpha-copaene (MESH:C000599751), ethanol (MESH:D000431), nitric oxide (MESH:D009569), eudesmanolides (MESH:C476916), retinoid (MESH:D012176), volatile oil (MESH:D009822), Terpenoids (MESH:D013729), streptozotocin (MESH:D013311), Grandifloric acid (MESH:C007885), phenolic acids (MESH:C017616), free radical (MESH:D005609), cyclic hydrocarbons (MESH:D006844), acetylsalicylic acid (MESH:D001241), water (MESH:D014867), beta-Caryophyllene oxide (MESH:C515179), carbamate (MESH:D002219), MDA (MESH:D008315), aliphatic acids (MESH:D005227), Neodarutoside (MESH:C062911), triterpenoids (MESH:D014315), MTT (MESH:C070243), isoflavone (MESH:D007529), germacrane (MESH:D045788), 1beta,6alpha-dihydroxy-4(14)-eudesmene (MESH:C477167), germacranolides (MESH:C432449), n-butanol (MESH:D020001), DOX (MESH:D004317), (+)-isolariciresinol (MESH:C060284), NO (MESH:D009614), annosquamosin A (MESH:C100908), 16alpha,17-dihydroxy-ent-kauran-19-oic acid (-), hydrogen peroxide (MESH:D006861), ethyl acetate (MESH:C007650), dihydrodehydrodiconiferyl alcohol (MESH:C489718)
- **Species:** Sigesbeckia orientalis (common St. Paul's wort, species) [taxon 185191], Mus musculus (house mouse, species) [taxon 10090], Salvia glabrescens (species) [taxon 428275], Sigesbeckia jorullensis (species) [taxon 185190], Bacillus subtilis (species) [taxon 1423], Verbesina occidentalis (species) [taxon 53738], Stenotrophomonas sp. O (species) [taxon 1355440], Sigesbeckia glabrescens (species) [taxon 371450], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], S. gracilis [taxon 626134], Sigesbeckia flosculosa (species) [taxon 185189], Simulium merga (species) [taxon 333337], Sigesbeckia pubescens (species) [taxon 714499], Sigesbeckia blakei (species) [taxon 183076]
- **Mutations:** C-16-C
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), Hep-G2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), RAW 264 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), BV2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182), PANC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480), RL95-2 — Homo sapiens (Human), Endometrial adenosquamous carcinoma, Cancer cell line (CVCL_0505), AsPC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0152), MC3T3-E1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0409), B16BL6 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0157)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12958691/full.md

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12958691/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12958691/full.md

---
Source: https://tomesphere.com/paper/PMC12958691